Form 4: Innovex International Insider Sells Shares
Statement of Changes in Beneficial Ownership
Adam Anderson, CEO and Director of Innovex International, reported a transaction involving the sale of 8,929 common shares.
Summary
- Adam Anderson, Chief Executive Officer and Director of Innovex International, Inc., engaged in a transaction on April 6, 2026.
- The transaction involved the withholding of 8,929 common shares to satisfy tax obligations related to the release of restricted stock units.
- Following this transaction, Mr. Anderson beneficially owns 505,253 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as the reported transaction is a standard tax withholding event rather than a discretionary sale of shares.
Negatives
- Insider Adam Anderson sold 8,929 shares of common stock.
Future Outlook
No specific future outlook or guidance was provided in this filing.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive stock activity. The withholding of shares for tax purposes is a common practice upon the vesting of restricted stock units.
Stakeholder Impact
- Shareholders: The transaction represents a reduction in the number of shares held by a key executive, though it is for tax purposes and not necessarily indicative of a change in confidence.
Key Dates
| Date | Description |
|---|---|
| 04/06/2026 | Transaction Date |
| 04/07/2026 | Date of Report |
Keywords
Innovex International, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Withholding, Adam Anderson, CEO, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.